Cited by 1,486HIV Research and TreatmentRNA regulation and diseaseHIV/AIDS drug development and treatment

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts

Open access

Mangeat, Bastien, Turelli, Priscilla, Caron, Gersende, Friedli, Marc, Perrin, Luc, Trono, Didier·2003·Nature

Open this paper in CoChat — free account

Abstract

Viral replication usually requires that innate intracellular lines of defence be overcome, a task usually accomplished by specialized viral gene products. The virion infectivity factor (Vif) protein of human immunodeficiency virus (HIV) is required during the late stages of viral production to counter the antiviral activity of APOBEC3G (apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G; also known as CEM15), a protein expressed notably in human T lymphocytes. When produced in the presence of APOBEC3G, vif-defective virus is non-infectious. APOBEC3G is closely related to APOBEC1, the central component of an RNA-editing complex that deaminates a cytosine residue in apoB messenger RNA. APOBEC family members also have potent DNA mutator activity through dC deamination; however, whether the editing potential of APOBEC3G has any relevance to HIV inhibition is unknown. Here, we demonstrate that it does, as APOBEC3G exerts its antiviral effect during reverse transcription to trigger G-to-A hypermutation in the nascent retroviral DNA. We also find that APOBEC3G can act on a broad range of retroviruses in addition to HIV, suggesting that hypermutation by editing is a general innate defence mechanism against this important group of pathogens.

Integrity signals

Registry

Crossref · 10.1038/nature01709

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
Sheehy, A. M., Gaddis, N., Choi, J. D., & Malim, M. H. (2002) · Nature · doi:10.1038/nature00939 · Cited by 2,407
Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo
Zufferey, R., Nagy, D., Mandel, R. J., Naldini, L., & Trono, D. (1997) · Nature Biotechnology · doi:10.1038/nbt0997-871 · Cited by 1,977
Self-citation
A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine
Powell, L. M., Wallis, S. C., Pease, R. J., Edwards, Y. H., Knott, T. J., & Scott, J. (1987) · Cell · doi:10.1016/0092-8674(87)90510-1 · Cited by 1,039
Transcription-targeted DNA deamination by the AID antibody diversification enzyme
Chaudhuri, J., Tian, M., Khuong, C., Chua, K. F., Pinaud, E., & Alt, F. W. (2003) · Nature · doi:10.1038/nature01574 · Cited by 746
An Anthropoid-Specific Locus of Orphan C to U RNA-Editing Enzymes on Chromosome 22
Jarmuz, A., Chester, A., Bayliss, J., Gisbourne, J., Dunham, I., Scott, J., & Navaratnam, N. (2002) · Genomics · doi:10.1006/geno.2002.6718 · Cited by 711
A quantitative assay for HIV DNA integration in vivo
Butler, S. L., Hansen, M. S., & Bushman, F. D. (2001) · Nature Medicine · doi:10.1038/87979 · Cited by 695
RNA Editing Enzyme APOBEC1 and Some of Its Homologs Can Act as DNA Mutators
Harris, R. S., Petersen‐Mahrt, S. K., & Neuberger, M. S. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00742-6 · Cited by 609
Molecular Cloning of an Apolipoprotein B Messenger RNA Editing Protein
Teng, B., Burant, C. F., & Davidson, N. O. (1993) · Science · doi:10.1126/science.8511591 · Cited by 536
Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes
Gabuzda, D. H., Lawrence, K., Langhoff, E., Terwilliger, E., Dorfman, T., Haseltine, W. A., & Sodroski, J. (1992) · Journal of Virology · doi:10.1128/jvi.66.11.6489-6495.1992 · Cited by 444
Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells
von Schwedler, U. K., Song, J., Aiken, C., & Trono, D. (1993) · Journal of Virology · doi:10.1128/jvi.67.8.4945-4955.1993 · Cited by 441
Self-citation

Flagged first, then by citations

Show all 28 references

Sorted by citations

Items 201–300 of 1,001

Structural Insight into the Human Immunodeficiency Virus Vif SOCS Box and Its Role in Human E3 Ubiquitin Ligase Assembly
Stanley, B. J., Ehrlich, E. S., Short, L., Yu, Y., Xiao, Z., Yu, X.-F., & Xiong, Y. (2008) · Journal of Virology · doi:10.1128/jvi.00767-08 · Cited by 138
Likely Role of APOBEC3G-Mediated G-to-A Mutations in HIV-1 Evolution and Drug Resistance
Jern, P., Russell, R. A., Pathak, V. K., & Coffin, J. M. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000367 · Cited by 131
Assembly of HIV-1 Vif-Cul5 E3 ubiquitin ligase through a novel zinc-binding domain-stabilized hydrophobic interface in Vif
Xiao, Z., Ehrlich, E. S., Yu, Y., Luo, K., Wang, T., Tian, C., & Yu, X.-F. (2006) · Virology · doi:10.1016/j.virol.2006.02.002 · Cited by 132
Resistance of human T cell leukemia virus type 1 to APOBEC3G restriction is mediated by elements in nucleocapsid
Derse, D., Hill, S. A., Princler, G. L., Lloyd, P. A., & Heidecker, G. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609444104 · Cited by 130
Vpr-mediated Incorporation of UNG2 into HIV-1 Particles Is Required to Modulate the Virus Mutation Rate and for Replication in Macrophages
Chen, R., Rouzic, E. L., Kearney, J. A., Mansky, L. M., & Bénichou, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403875200 · Cited by 130
Differential Requirement for Conserved Tryptophans in Human Immunodeficiency Virus Type 1 Vif for the Selective Suppression of APOBEC3G and APOBEC3F
Tian, C., Yu, X., Zhang, W., Wang, T., Xu, R., & Yu, X.-F. (2006) · Journal of Virology · doi:10.1128/jvi.80.6.3112-3115.2006 · Cited by 129
Characterization of Conserved Motifs in HIV-1 Vif Required for APOBEC3G and APOBEC3F Interaction
He, Z., Zhang, W., Chen, G., Xu, R., & Yu, X.-F. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.06.061 · Cited by 129
Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: A review
Girard, M. P., Osmanov, S., Assossou, O. M., & Kiény, M.-P. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.06.085 · Cited by 139
Mice Deficient in APOBEC2 and APOBEC3
Mikl, M. C., Watt, I. N., Lu, M., Reik, W., Davies, S. L., Neuberger, M. S., & Rada, C. A. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.16.7270-7277.2005 · Cited by 127
Modelling the spatial heterogeneity and molecular correlates of lymphocytic infiltration in triple-negative breast cancer
Yuan, Y. (2014) · Journal of The Royal Society Interface · doi:10.1098/rsif.2014.1153 · Cited by 128
Restriction of HIV-1 replication in macrophages and CD4+ T cells from HIV controllers
Sáez‐Cirión, A., Hamimi, C., Bergamaschi, A., David, A., Versmisse, P., Mélard, A., Boufassa, F., Barré‐Sinoussi, F., Lambotte, O., Rouzioux, C., et al. (2011) · Blood · doi:10.1182/blood-2010-12-327106 · Cited by 126
Structure, interaction and real‐time monitoring of the enzymatic reaction of wild‐type APOBEC3G
Furukawa, A., Nagata, T., Matsugami, A., Habu, Y., Sugiyama, R., Hayashi, F., Kobayashi, N., Yokoyama, S., Takaku, H., & Katahira, M. (2009) · The EMBO Journal · doi:10.1038/emboj.2008.290 · Cited by 125
Antiretroviral potential of human tripartite motif-5 and related proteins
Zhang, F., Hatziioannou, T., Pérez-Caballero, D., Derse, D., & Bieniasz, P. D. (2006) · Virology · doi:10.1016/j.virol.2006.05.035 · Cited by 125
The Interaction of APOBEC3G with Human Immunodeficiency Virus Type 1 Nucleocapsid Inhibits tRNA 3 Lys Annealing to Viral RNA
Guo, F., Cen, S., Niu, M., Yang, Y., Gorelick, R. J., & Kleiman, L. (2007) · Journal of Virology · doi:10.1128/jvi.00162-07 · Cited by 124
Interferon Alpha Subtype-Specific Suppression of HIV-1 Infection In Vivo
Lavender, K. J., Sutter, K., Peterson, K. E., Dis, E. S. V., Francois, S., Woods, T. A., Messer, R. J., Gawanbacht, A., Müller, J. A., Münch, J., et al. (2016) · Journal of Virology · doi:10.1128/jvi.00451-16 · Cited by 131
The evolving genomic landscape of urothelial carcinoma
Glaser, A. P., Fantini, D., Shilatifard, A., Schaeffer, E. M., & Meeks, J. J. (2017) · Nature Reviews Urology · doi:10.1038/nrurol.2017.11 · Cited by 126
Role of APOBEC3 in Genetic Diversity among Endogenous Murine Leukemia Viruses
Jern, P., Stoye, J. P., & Coffin, J. M. (2005) · PLoS Genetics · doi:10.1371/journal.pgen.0030183 · Cited by 122
Non-long terminal repeat (non-LTR) retrotransposons: mechanisms, recent developments, and unanswered questions
Han, J. S. (2010) · Mobile DNA · doi:10.1186/1759-8753-1-15 · Cited by 132
Derepression of MicroRNA-mediated Protein Translation Inhibition by Apolipoprotein B mRNA-editing Enzyme Catalytic Polypeptide-like 3G (APOBEC3G) and Its Family Members
Huang, J., Liang, Z.-H., Yang, B., Tian, H., Ma, J., & Zhang, H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705116200 · Cited by 128
Novel targets for HIV therapy
Greene, W. C., Debyser, Z., Ikeda, Y., Freed, E. O., Stephens, E. B., Yonemoto, W. M., Buckheit, R. W., Esté, J. A., & Cihlář, T. (2008) · Antiviral Research · doi:10.1016/j.antiviral.2008.08.003 · Cited by 121
APOBEC3F and APOBEC3G Inhibit HIV-1 DNA Integration by Different Mechanisms
Mbisa, J. L., Bu, W., & Pathak, V. K. (2010) · Journal of Virology · doi:10.1128/jvi.02358-09 · Cited by 120
HIV-1 Vpr—a still “enigmatic multitasker”
Guenzel, C. A., Hérate, C., & Bénichou, S. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00127 · Cited by 137
Crystal Structure of the APOBEC3G Catalytic Domain Reveals Potential Oligomerization Interfaces
Shandilya, S. M. D., Nalam, M. N. L., Nalivaika, E. A., Gross, P. J., Valesano, J. C., Shindo, K., Li, M., Munson, M., Royer, W. E., Harjes, E., et al. (2010) · Structure · doi:10.1016/j.str.2009.10.016 · Cited by 119
Dual inhibitory effects of APOBEC family proteins on retrotransposition of mammalian endogenous retroviruses
Esnault, C. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl054 · Cited by 119
APOBEC3G/CEM15 (hA3G) mRNA Levels Associate Inversely with Human Immunodeficiency Virus Viremia
Jin, X., Brooks, A., Chen, H., Bennett, R. P., Reichman, R. C., & Smith, H. C. (2005) · Journal of Virology · doi:10.1128/jvi.79.17.11513-11516.2005 · Cited by 119
Twin gradients in APOBEC3 edited HIV-1 DNA reflect the dynamics of lentiviral replication
Suspène, R., Rusniok, C., Vartanian, J., & Wain–Hobson, S. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl555 · Cited by 118
Generation of HIV-1 derivatives that productively infect macaque monkey lymphoid cells
Kamada, K., Igarashi, T., Martin, M. A., Khamsri, B., Hatcho, K., Yamashita, T., Fujita, M., Uchiyama, T., & Adachi, A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608289103 · Cited by 117
Structural Model for Deoxycytidine Deamination Mechanisms of the HIV-1 Inactivation Enzyme APOBEC3G
Chelico, L., Prochnow, C., Erie, D. A., Chen, X. S., & Goodman, M. F. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.107987 · Cited by 116
Mouse APOBEC3 Restricts Friend Leukemia Virus Infection and Pathogenesis In Vivo
Takeda, E., Tsuji-Kawahara, S., Sakamoto, M., Langlois, M., Neuberger, M. S., Rada, C. A., & Miyazawa, M. (2008) · Journal of Virology · doi:10.1128/jvi.01311-08 · Cited by 116
Human APOBEC3G-Mediated Editing Can Promote HIV-1 Sequence Diversification and Accelerate Adaptation to Selective Pressure
Kim, E., Tanmoy Bhattacharya, A., Kunstman, K., Swantek, P., Koning, F. A., Malim, M. H., & Wolinsky, S. M. (2010) · Journal of Virology · doi:10.1128/jvi.01223-10 · Cited by 115
Development of benzimidazole derivatives to inhibit HIV-1 replication through protecting APOBEC3G protein
Pan, T. S., He, X., Chen, B., Chen, H., Geng, G., Luo, H., Zhang, H., & Bai, C. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.03.050 · Cited by 114
Gene Loss and Adaptation to Hominids Underlie the Ancient Origin of HIV-1
Etienne, L., Hahn, B. H., Sharp, P. M., Matsen, F. A., IV, & Emerman, M. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.06.002 · Cited by 118
Human Cytidine Deaminase APOBEC3H Restricts HIV-1 Replication
Dang, Y., Siew, L. M., Wang, X., Han, Y., Lampen, R. J., & Zheng, Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707586200 · Cited by 114
Intrinsic Obstacles to Human Immunodeficiency Virus Type 1 Coreceptor Switching
Pastore, C., Ramos, A. G., & Mosier, D. E. (2004) · Journal of Virology · doi:10.1128/jvi.78.14.7565-7574.2004 · Cited by 114
Suppression of APOBEC3-mediated restriction of HIV-1 by Vif
Feng, Y., Baig, T. T., Love, R. P., & Chelico, L. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00450 · Cited by 113
Small Interfering RNA Profiling Reveals Key Role of Clathrin-Mediated Endocytosis and Early Endosome Formation for Infection by Respiratory Syncytial Virus
Kolokoltsov, A. A., Deniger, D. C., Fleming, E. H., Roberts, N. J., Karpilow, J. M., & Davey, R. A. (2007) · Journal of Virology · doi:10.1128/jvi.02780-06 · Cited by 116
APOBEC3G Multimers Are Recruited to the Plasma Membrane for Packaging into Human Immunodeficiency Virus Type 1 Virus-Like Particles in an RNA-Dependent Process Requiring the NC Basic Linker
Burnett, A. S., & Spearman, P. W. (2007) · Journal of Virology · doi:10.1128/jvi.02237-06 · Cited by 113
Viral complementation allows HIV-1 replication without integration
Gelderblom, H. C., Vatakis, D. N., Burke, S. A., Lawrie, S. D., Bristol, G. C., & Levy, D. N. (2008) · Retrovirology · doi:10.1186/1742-4690-5-60 · Cited by 121
APOBEC3G Restricts HIV-1 to a Greater Extent than APOBEC3F and APOBEC3DE in Human Primary CD4 + T Cells and Macrophages
Chaipan, C., Smith, J. L., Hu, W.-S., & Pathak, V. K. (2012) · Journal of Virology · doi:10.1128/jvi.00676-12 · Cited by 112
Convergence and Divergence in the Evolution of the APOBEC3G-Vif Interaction Reveal Ancient Origins of Simian Immunodeficiency Viruses
Compton, A. A., & Emerman, M. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003135 · Cited by 117
Roles of HIV-1 auxiliary proteins in viral pathogenesis and host-pathogen interactions
Li, L., Li, H. S., Pauza, C. D., Bukrinsky, M., & Zhao, Y. (2005) · Cell Research · doi:10.1038/sj.cr.7290370 · Cited by 126
Analysis of Human APOBEC3H Haplotypes and Anti-Human Immunodeficiency Virus Type 1 Activity
Wang, X., Abudu, A., Son, S., Dang, Y., Venta, P. J., & Zheng, Y. (2011) · Journal of Virology · doi:10.1128/jvi.02049-10 · Cited by 111
Mutation Rates and Intrinsic Fidelity of Retroviral Reverse Transcriptases
Menéndez‐Arias, L. (2009) · Viruses · doi:10.3390/v1031137 · Cited by 114
Genome-wide somatic hypermutation
Wang, C. L., Harper, R. A., & Wabl, M. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402009101 · Cited by 111
A critical function of toll‐like receptor‐3 in the induction of anti‐human immunodeficiency virus activities in macrophages
Zhou, Y., Wang, X., Liu, M., Hu, Q., Song, L., Ye, L., Zhou, D., & Ho, W. (2010) · Immunology · doi:10.1111/j.1365-2567.2010.03270.x · Cited by 111
Identification of an APOBEC3G Binding Site in Human Immunodeficiency Virus Type 1 Vif and Inhibitors of Vif-APOBEC3G Binding
Mehle, A., Wilson, H., Zhang, C., Brazier, A. J., McPike, M. P., Pery, E., & Gabuzda, D. H. (2007) · Journal of Virology · doi:10.1128/jvi.00204-07 · Cited by 109
Feline Immunodeficiency Virus (FIV) as A Model for Study of Lentivirus Infections: Parallels with HIV
Elder, J. H., Lin, Y., Fink, E. A., & Grant, C. K. (2010) · Current HIV Research · doi:10.2174/157016210790416389 · Cited by 109
Rapid Evolution of HIV-1 to Functional CD8 + T Cell Responses in Humanized BLT Mice
Dudek, T. E., No, D. C., Seung, E., Vrbanac, V. D., Fadda, L., Bhoumik, P., Boutwell, C. L., Power, K. A., Gladden, A. D., Battis, L., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003984 · Cited by 108
Suppression of HIV-1 Infection by APOBEC3 Proteins in Primary Human CD4 + T Cells Is Associated with Inhibition of Processive Reverse Transcription as Well as Excessive Cytidine Deamination
Gillick, K., Pollpeter, D., Phalora, P. K., Kim, E., Wolinsky, S. M., & Malim, M. H. (2012) · Journal of Virology · doi:10.1128/jvi.02587-12 · Cited by 116
The Cellular Antiviral Protein APOBEC3G Interacts with HIV-1 Reverse Transcriptase and Inhibits Its Function during Viral Replication
Wang, X., Ao, Z., Chen, L., Kobinger, G., Peng, J., & Yao, X. (2012) · Journal of Virology · doi:10.1128/jvi.06594-11 · Cited by 112
Good to CU
Gu, Y., & Sundquist, W. I. (2003) · Nature · doi:10.1038/424021a · Cited by 107
Differential Inhibition of Long Interspersed Element 1 by APOBEC3 Does Not Correlate with High-Molecular-Mass-Complex Formation or P-Body Association
Niewiadomska, A. M., Tian, C., Tan, L., Wang, T., Sarkis, P. T. N., & Yu, X.-F. (2007) · Journal of Virology · doi:10.1128/jvi.02800-06 · Cited by 107
An Overview of Cytidine Deaminases
Navaratnam, N., & Sarwar, R. (2006) · International Journal of Hematology · doi:10.1532/ijh97.06032 · Cited by 107
Protein intrinsic disorder as a flexible armor and a weapon of HIV-1
Xue, B., Mizianty, M. J., Kurgan, L., & Uversky, V. N. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0859-3 · Cited by 107
The double-domain cytidine deaminase APOBEC3G is a cellular site-specific RNA editing enzyme
Sharma, S., Patnaik, S. K., Taggart, R. T., & Baysal, B. E. (2016) · Scientific Reports · doi:10.1038/srep39100 · Cited by 97
APOBEC3 genes: retroviral restriction factors to cancer drivers
Henderson, S. R., & Fenton, T. R. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.02.007 · Cited by 107
Innate Immune Signaling Induces High Levels of TC-specific Deaminase Activity in Primary Monocyte-derived Cells through Expression of APOBEC3A Isoforms
Thielen, B. K., McNevin, J. P., McElrath, M. J., Hunt, B. V. S., Klein, K. C., & Lingappa, J. R. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.102822 · Cited by 106
Components of Promyelocytic Leukemia Nuclear Bodies (ND10) Act Cooperatively To Repress Herpesvirus Infection
Glaß, M., & Everett, R. D. (2012) · Journal of Virology · doi:10.1128/jvi.02950-12 · Cited by 106
Current status of gene therapy strategies to treat HIV/AIDS
Strayer, D. S., Akkina, R., Bunnell, B. A., Dropulić, B., Planelles, V., Pomerantz, R. J., Rossi, J. J., & Zaia, J. A. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.01.020 · Cited by 106
Comparative analysis of the antiretroviral activity of APOBEC3G and APOBEC3F from primates
Zennou, V., & Bieniasz, P. D. (2006) · Virology · doi:10.1016/j.virol.2005.12.035 · Cited by 106
Genetic Association of the Antiviral Restriction Factor TRIM5α with Human Immunodeficiency Virus Type 1 Infection
Speelmon, E. C., Livingston‐Rosanoff, D., Li, S. S., Vu, Q., Bui, J. K., Geraghty, D. E., Zhao, L. P., & McElrath, M. J. (2006) · Journal of Virology · doi:10.1128/jvi.80.5.2463-2471.2006 · Cited by 106
APOBEC3G Targets Specific Virus Species
Kobayashi, M., Takaori‐Kondo, A., Shindo, K., Abudu, A., Fukunaga, K., & Uchiyama, T. (2004) · Journal of Virology · doi:10.1128/jvi.78.15.8238-8244.2004 · Cited by 106
Antibody diversification by somatic mutation: from Burnet onwards
Neuberger, M. S. (2008) · Immunology and Cell Biology · doi:10.1038/sj.icb.7100160 · Cited by 105
Host hindrance to HIV-1 replication in monocytes and macrophages
Bergamaschi, A., & Pancino, G. (2010) · Retrovirology · doi:10.1186/1742-4690-7-31 · Cited by 112
Hypermutation by intersegmental transfer of APOBEC3G cytidine deaminase
Nowarski, R., Britan‐Rosich, E., Shiloach, T., & Kotler, M. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1495 · Cited by 104
A Model for Oligomeric Regulation of APOBEC3G Cytosine Deaminase-dependent Restriction of HIV
Chelico, L., Sacho, E. J., Erie, D. A., & Goodman, M. F. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801004200 · Cited by 104
Mutational Alteration of Human Immunodeficiency Virus Type 1 Vif Allows for Functional Interaction with Nonhuman Primate APOBEC3G
Schröfelbauer, B., Senger, T., Manning, G., & Landau, N. R. (2006) · Journal of Virology · doi:10.1128/jvi.00388-06 · Cited by 104
Mechanoresponsive stem cells to target cancer metastases through biophysical cues
Liu, L., Zhang, S. X., Liao, W., Farhoodi, H. P., Wong, C. W., Chen, C. C., Ségaliny, A. I., Chacko, J. V., Nguyen, L., Lu, M., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aan2966 · Cited by 104
Stoichiometry of the antiviral protein APOBEC3G in HIV-1 virions
Xu, H., Chertova, E. N., Chen, J., Ott, D. E., Roser, J. D., Hu, W.-S., & Pathak, V. K. (2006) · Virology · doi:10.1016/j.virol.2006.10.036 · Cited by 103
HIV-1 Vif Adaptation to Human APOBEC3H Haplotypes
Ooms, M., Brayton, B., Letko, M. C., Maio, S. M., Pilcher, C. D., Hecht, F. M., Barbour, J. D., & Simon, V. R. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.09.006 · Cited by 102
APOBEC3B can impair genomic stability by inducing base substitutions in genomic DNA in human cells
Shinohara, M., Io, K., Shindo, K., Matsui, M., Sakamoto, T., Tada, K., Kobayashi, M., Kadowaki, N., & Takaori‐Kondo, A. (2012) · Scientific Reports · doi:10.1038/srep00806 · Cited by 103
Host range, host specificity and hypothesized host shift events among viruses of lower vertebrates
Bandı́n, I., & Dopazo, C. P. (2011) · Veterinary Research · doi:10.1186/1297-9716-42-67 · Cited by 102
Prime, Shock, and Kill: Priming CD4 T Cells from HIV Patients with a BCL-2 Antagonist before HIV Reactivation Reduces HIV Reservoir Size
Cummins, N. W., Sainski, A. M., Dai, H., Natesampillai, S., Pang, Y., Bren, G. D., Correia, M. C. M. D. A., Sampath, R., Rizza, S. A., O’Brien, D. R., et al. (2016) · Journal of Virology · doi:10.1128/jvi.03179-15 · Cited by 102
An Extended Structure of the APOBEC3G Catalytic Domain Suggests a Unique Holoenzyme Model
Harjes, E., Gross, P. J., Chen, K., Lu, Y., Shindo, K., Nowarski, R., Gross, J. D., Kotler, M., Harris, R. S., & Matsuo, H. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.04.031 · Cited by 101
Distinct Domains within APOBEC3G and APOBEC3F Interact with Separate Regions of Human Immunodeficiency Virus Type 1 Vif
Russell, R. A., Smith, J. L., Barr, R., Bhattacharyya, D., & Pathak, V. K. (2008) · Journal of Virology · doi:10.1128/jvi.01621-08 · Cited by 100
Crystal Structure of the DNA Cytosine Deaminase APOBEC3F: The Catalytically Active and HIV-1 Vif-Binding Domain
Bohn, M., Shandilya, S. M. D., Albin, J. S., Kouno, T., Anderson, B. D., McDougle, R. M., Carpenter, M. A., Rathore, A. S., Evans, L., Davis, A. N., et al. (2013) · Structure · doi:10.1016/j.str.2013.04.010 · Cited by 103
Susceptibility of xenotropic murine leukemia virus-related virus (XMRV) to retroviral restriction factors
Groom, H. C. T., Yap, M. W., Galão, R. P., Neil, S. J. D., & Bishop, K. N. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913650107 · Cited by 100
Roles of APOBEC3A and APOBEC3B in Human Papillomavirus Infection and Disease Progression
Warren, C. J., Westrich, J. A., Doorslaer, K. V., & Pyeon, D. (2017) · Viruses · doi:10.3390/v9080233 · Cited by 105
Retroviruses drive the rapid evolution of mammalian APOBEC3 genes
Ito, J., Gifford, R. J., & Sato, K. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1914183116 · Cited by 106
Human Immunodeficiency Virus Type 1 Vif Inhibits Packaging and Antiviral Activity of a Degradation-Resistant APOBEC3G Variant
Opi, S., Kao, S., Goila-Gaur, R., Khan, M. A., Miyagi, E., Takeuchi, H., & Strebel, K. (2007) · Journal of Virology · doi:10.1128/jvi.02694-06 · Cited by 99
Role of viral regulatory and accessory proteins in HIV-1 replication
Seelamgari, A. (2004) · Frontiers in Bioscience · doi:10.2741/1403 · Cited by 98
HIV-1 Protease, Reverse Transcriptase, and Integrase Variation
Rhee, S., Sankaran, K., Varghese, V., Winters, M. A., Hurt, C. B., Eron, J. J., Parkin, N. T., Holmes, S., Holodniy, M., & Shafer, R. W. (2016) · Journal of Virology · doi:10.1128/jvi.00495-16 · Cited by 98
Potential APOBEC-mediated RNA editing of the genomes of SARS-CoV-2 and other coronaviruses and its impact on their longer term evolution
Ratcliff, J., & Simmonds, P. (2021) · Virology · doi:10.1016/j.virol.2020.12.018 · Cited by 108
APOBEC3 Deaminases Induce Hypermutation in Human Papillomavirus 16 DNA upon Beta Interferon Stimulation
Wang, Z., Wakae, K., KITAMURA, K., Aoyama, S., Liu, G., Koura, M., Monjurul, A. M., Kukimoto, I., & Muramatsu, M. (2013) · Journal of Virology · doi:10.1128/jvi.03091-13 · Cited by 98
Deep sequencing of HIV-1 reverse transcripts reveals the multifaceted antiviral functions of APOBEC3G
Pollpeter, D., Parsons, M., Sobala, A., Coxhead, S., Lang, R. D., Bruns, A. M., Papaioannou, S., McDonnell, J. M., Apolonia, L., Chowdhury, J. A., et al. (2017) · Nature Microbiology · doi:10.1038/s41564-017-0063-9 · Cited by 101
HIV-1 and MLV Gag proteins are sufficient to recruit APOBEC3G into virus-like particles
Douaisi, M. P., Dussart, S., Courcoul, M., Bessou, G., Vigne, R., & Decroly, É. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.07.005 · Cited by 97
APOBEC3A, APOBEC3B, and APOBEC3H Haplotype 2 Restrict Human T-Lymphotropic Virus Type 1
Ooms, M., Krikoni, A., Thoma‐Kress, A. K., Simon, V. R., & Münk, C. (2012) · Journal of Virology · doi:10.1128/jvi.06570-11 · Cited by 101
Endogenous Origins of HIV-1 G-to-A Hypermutation and Restriction in the Nonpermissive T Cell Line CEM2n
Refsland, E. W., Hultquist, J. F., & Harris, R. S. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002800 · Cited by 99
Host restriction factors in retroviral infection: promises in virus-host interaction
Zheng, Y., Jeang, K.-T., & Tokunaga, K. (2012) · Retrovirology · doi:10.1186/1742-4690-9-112 · Cited by 106
The role of cullin 5-containing ubiquitin ligases
Okumura, F., Akiko, J.-O., Nakatsukasa, K., & Kamura, T. (2016) · Cell Division · doi:10.1186/s13008-016-0016-3 · Cited by 99
HIV-1-Associated Uracil DNA Glycosylase Activity Controls dUTP Misincorporation in Viral DNA and Is Essential to the HIV-1 Life Cycle
Priet, S., Gros, N., Navarro, J., Boretto, J., Canard, B., Quérat, G., & Sire, J. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.01.016 · Cited by 96
Double-Stranded RNA Adenosine Deaminases Enhance Expression of Human Immunodeficiency Virus Type 1 Proteins
Phuphuakrat, A., Kraivong, R., Boonarkart, C., Lauhakirti, D., Lee, T., & Auewarakul, P. (2008) · Journal of Virology · doi:10.1128/jvi.00238-08 · Cited by 96
Human APOBEC3A Isoforms Translocate to the Nucleus and Induce DNA Double Strand Breaks Leading to Cell Stress and Death
Mußil, B., Suspène, R., Aynaud, M.-M., Gauvrit, A., Vartanian, J., & Wain–Hobson, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073641 · Cited by 98
STAT1-Independent Cell Type-Specific Regulation of Antiviral APOBEC3G by IFN-α
Sarkis, P. T. N., Ying, S., Xu, R., & Yu, X.-F. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.7.4530 · Cited by 96
Production of infectious human immunodeficiency virus type 1 does not require depletion of APOBEC3G from virus-producing cells
Kao, S., Miyagi, E., Khan, M. A., Takeuchi, H., Opi, S., Goila-Gaur, R., & Strebel, K. (2004) · Retrovirology · doi:10.1186/1742-4690-1-27 · Cited by 94
The biased nucleotide composition of the HIV genome: a constant factor in a highly variable virus
van der Kuyl, A. C., & Berkhout, B. (2012) · Retrovirology · doi:10.1186/1742-4690-9-92 · Cited by 94
Contribution of type W human endogenous retroviruses to the human genome: characterization of HERV-W proviral insertions and processed pseudogenes
Grandi, N., Cadeddu, M., Blomberg, J., & Tramontano, E. (2016) · Retrovirology · doi:10.1186/s12977-016-0301-x · Cited by 96
Regulation of APOBEC3 Proteins by a Novel YXXL Motif in Human Immunodeficiency Virus Type 1 Vif and Simian Immunodeficiency Virus SIVagm Vif
Pery, E., Rajendran, K. S., Brazier, A. J., & Gabuzda, D. H. (2008) · Journal of Virology · doi:10.1128/jvi.01898-08 · Cited by 92
Cullin-RING E3 Ubiquitin Ligases: Bridges to Destruction
Nguyen, H. C., Wang, W., & Xiong, Y. (2017) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-319-46503-6_12 · Cited by 102
Nanostructures of APOBEC3G Support a Hierarchical Assembly Model of High Molecular Mass Ribonucleoprotein Particles from Dimeric Subunits
Wedekind, J. E., Gillilan, R. E., Markmann, A. J., Krucinska, J., Salter, J. D., Bennett, R. P., Raina, J., & Smith, H. C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.c600253200 · Cited by 92

Authors: Mangeat, B., Turelli, P., Caron, G., Friedli, M., Perrin, L., & Trono, D.
Affiliations: University of Geneva (CH)
Corresponding author: Trono, Didier
ORCID: Mangeat, Bastien
Turelli, Priscilla
Caron, Gersende
Trono, Didier
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2003-05-28
Volume: 424
Issue: 6944
Pages: 99-103
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature01709
OpenAlex: W1966343819
Cited by: 1,486
References: 28
Citations by year: 2026: 20 · 2025: 29 · 2024: 23 · 2023: 28 · 2022: 25 · 2021: 43 · 2020: 37 · 2019: 53 · 2018: 49 · 2017: 56 · 2016: 58 · 2015: 58 · 2014: 79 · 2013: 87 · 2012: 97
FWCI: 36.98
Type: journal article
Language: en
Open access: green
infoscience.epfl.ch
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
Topics: Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
Keywords: APOBEC3G, HIV-1 Vif, APOBEC1, cytosine deamination, reverse transcription, G-to-A hypermutation, retrovirus restriction, T cells, RNA editing
MeSH terms: APOBEC-3G Deaminase, Antiviral Agents, Base Sequence, Cell Line, Cytidine Deaminase, DNA, Viral, Humans, Molecular Sequence Data, Nucleoside Deaminases, Proteins, Repressor Proteins, RNA, Messenger, Transcription, Genetic, Virus Replication, HIV-1, Mutagenesis, Gene Products, vif, Point Mutation, RNA Editing, Viral Load, vif Gene Products, Human Immunodeficiency Virus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks